Navigation Links
Policy transparency key to saving world's fisheries
Date:6/22/2009

dy showed that out of several attributes analysed, the transparency with which scientific recommendations are turned into policy plays the strongest role in the fate of fisheries sustainability.

"Policy-making is at the centre of the entire process of fisheries management," explains co-author Marta Coll, at the Institut de Cinces del Mar in Spain. "If this is heavily influenced by political pressures or corruption, it is unlikely that good scientific advice will ever be translated into proper regulations. Similarly, authoritarism in this process is likely to reduce compliance with the resulting policies."

"Several examples provide evidence supporting the results of this study," says Carl Safina at the Blue Ocean Institute, who was not involved in the study. "Many developed countries, including the European Union, the United States and Canada, which have access to perhaps some of the best science available, have witnessed some of the most dramatic collapses known to us, such as the collapse of the cod and haddock in the early 1990s. All of this because of high pressures on the process of policy-making to increase catches, despite scientific advice to reduce them."

"A similar situation occurs with the quotas for bluefin tuna in the Mediterranean," explains Safina. "In this case, concerns about the collapse of this stock have led scientists to recommend quotas that have been almost doubled due to strong pressures in the process of policy-making."

"For developing nations the situation is more regrettable, given that many of these countries, particularly in Africa and Oceania, face shortages in food supply," says coauthor Rashid Sumaila at the University of British Columbia. "We know, for instance, that in many of these nations, shark populations have been decimated as a result of shark fining. Unfortunately the regulation of this activity remains largely ineffective, most commonly as a result of corruption while generating or enforci
'/>"/>

Contact: Catherine Muir
cmuir@mathstat.dal.ca
902-494-2146
Dalhousie University
Source:Eurekalert

Page: 1 2 3 4 5

Related biology news :

1. Scientists aim to bring indigenous people into climate change monitoring and policy
2. AIBS names 2009 emerging public policy leaders
3. Reforming defense department acquisition policy: UM expert
4. Public Policy Center hosts flood symposium March 10-12
5. MacArthur Foundation awards planning grant to improve decision-making in energy policy
6. Diverse landscapes are better: Policymakers urged to think broadly about biofuel crops
7. Diverse landscapes are better: Policymakers urged to think broadly about biofuel crops
8. Fiddler crabs reveal honesty is not always the best policy
9. Advice to the new administration: UM foreign and domestic policy guide
10. Mandate for biofuels production requires science-based policy and global perspective
11. Thinking it through: Scientists call for policy to guide biofuels industry toward sustainability
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/31/2015)... , Kina, 31. juli 2015 Den ... bliver afholdt af BGI fra den 22. - 25. oktober ... Konferencen fejrer sin 10-års fødselsdag i år. Siden ... mest indflydelsesrige årlige møder på ,omik,-feltet, og er en ... ICG-10 fokuserer på nylige gennembrud og ...
(Date:7/31/2015)... SHENZHEN, China , 31 de julio de 2015 ... sobre Genómica (ICG-10,  www.icg-10.org ) del 22 al 25 ... . La conferencia celebra su décimo ... se ha convertido en una de las reuniones anuales ... ,ómicas, y es una de las conferencias científicas más ...
(Date:7/31/2015)... 31 de julho de 2015 A 10 ... ) será realizada pela BGI de 22-25 de outubro de ... A conferência está celebrando seu 10 o. ... ICG se tornou uma das reuniões mais influentes do ... científicos mais dinâmicos, entusiastas e prazerosos. ...
Breaking Biology News(10 mins):Den 10. internationale konference om Genomics (ICG-10) åbner i oktober 2La 10ª Conferencia Internacional sobre Genómica (ICG-10) comienza en octubre 2La 10ª Conferencia Internacional sobre Genómica (ICG-10) comienza en octubre 3A 10a. Conferência Internacional sobre Genômica (ICG-10) será em outubro 2A 10a. Conferência Internacional sobre Genômica (ICG-10) será em outubro 3
... (June 17, 2008) For those patients who receive ... treat their B12 deficiency, a new oral option may ... of Health, vitamin B12 deficiency can lead to a ... reduced cognitive functioning. Vitamin B12 deficiency is a significant ...
... . Montreal, 13 June 2008 ... University and the University of British Columbia (UBC) determined ... increase in serious adverse events, but are associated with ... Several drugs containing compounds derived from the cannabis plant, ...
... Assistant Investigator, has been named a Pew Scholar in ... carries an award of $240,000 over four years. ... selected on the basis of performance during education and ... science relevant to human health. The Pew Charitable Trusts ...
Cached Biology News:New technology may prevent vitamin B12 deficient seniors and vegetarians from needing injections 2Medicines derived from cannabis: a review of adverse events 2Julia Zeitlinger named Pew Scholar 2
(Date:7/29/2015)... SYDNEY , July 29, 2015 US-Australian ... NVGN ) today confirmed it is committed to progressing ... as soon as practicable and to ensure the Company ... Chief Executive Officer, Iain Ross , said the ... including the lead pre-clinical programs, discovery programs and academic ...
(Date:7/29/2015)... 2015  HealthSouth Corporation (NYSE: HLS ... post-acute healthcare services, offering both facility-based and home-based ... for the second quarter ended June 30, 2015. ... strong volume growth in both segments and an ... Grinney, President and Chief Executive Officer of HealthSouth. ...
(Date:7/29/2015)... 29, 2015 Research ... addition of the "Global Biosimilars Market, 2015 ... The Global Biosimilars Market, 2015 - 2025, ... growing biosimilars market. With the blockbuster biologics losing ... costs, biosimilars are being viewed as viable substitutes ...
(Date:7/29/2015)... NEW YORK , July 29, 2015 /PRNewswire/ ... neuropathology testing, announces increased partnerships with VA and ... offers Epidermal Nerve Fiber Density (ENFD) and Sweat ... of small fiber neuropathy ( https://therapath.com/skin ). ... Epidermal Nerve Fiber Density (ENFD) on punch skin ...
Breaking Biology Technology:Newly Appointed Acting CEO Outlines Immediate Plans for Novogen 2Newly Appointed Acting CEO Outlines Immediate Plans for Novogen 3Newly Appointed Acting CEO Outlines Immediate Plans for Novogen 4Newly Appointed Acting CEO Outlines Immediate Plans for Novogen 5Newly Appointed Acting CEO Outlines Immediate Plans for Novogen 6Newly Appointed Acting CEO Outlines Immediate Plans for Novogen 7Newly Appointed Acting CEO Outlines Immediate Plans for Novogen 8Newly Appointed Acting CEO Outlines Immediate Plans for Novogen 9Newly Appointed Acting CEO Outlines Immediate Plans for Novogen 10HealthSouth Reports Results for Second Quarter 2015 2HealthSouth Reports Results for Second Quarter 2015 3HealthSouth Reports Results for Second Quarter 2015 4HealthSouth Reports Results for Second Quarter 2015 5HealthSouth Reports Results for Second Quarter 2015 6HealthSouth Reports Results for Second Quarter 2015 7HealthSouth Reports Results for Second Quarter 2015 8HealthSouth Reports Results for Second Quarter 2015 9HealthSouth Reports Results for Second Quarter 2015 10HealthSouth Reports Results for Second Quarter 2015 11HealthSouth Reports Results for Second Quarter 2015 12HealthSouth Reports Results for Second Quarter 2015 13HealthSouth Reports Results for Second Quarter 2015 14HealthSouth Reports Results for Second Quarter 2015 15HealthSouth Reports Results for Second Quarter 2015 16HealthSouth Reports Results for Second Quarter 2015 17HealthSouth Reports Results for Second Quarter 2015 18HealthSouth Reports Results for Second Quarter 2015 19HealthSouth Reports Results for Second Quarter 2015 20HealthSouth Reports Results for Second Quarter 2015 21HealthSouth Reports Results for Second Quarter 2015 22HealthSouth Reports Results for Second Quarter 2015 23HealthSouth Reports Results for Second Quarter 2015 24HealthSouth Reports Results for Second Quarter 2015 25HealthSouth Reports Results for Second Quarter 2015 26HealthSouth Reports Results for Second Quarter 2015 27
... York, August 15 XTL,Biopharmaceuticals Ltd. (NASDAQ: ... engaged in the acquisition, development and,commercialization of therapeutics ... pain and hepatitis C, today announced its,financial results ... At June 30, 2007, the Company had ...
... Chilcott,Limited (Nasdaq: WCRX ) announced today that it ... Inc. ("Barr") advising the,Company of the filing of an ... FEMCON FE. FEMCON FE, which was introduced by ... chewable oral contraceptive and is protected by U.S. Patent,No. ...
... Aug. 15 Thoratec,Corporation (Nasdaq: THOR ), a ... that its PMA (PreMarket Application),seeking approval of its HeartMate ... panel later this year. The company said that ... date for the review by a Circulatory Systems Device ...
Cached Biology Technology:XTL Biopharmaceuticals Announces Financial Results for the Six Months Ended June 30, 2007 2XTL Biopharmaceuticals Announces Financial Results for the Six Months Ended June 30, 2007 3XTL Biopharmaceuticals Announces Financial Results for the Six Months Ended June 30, 2007 4XTL Biopharmaceuticals Announces Financial Results for the Six Months Ended June 30, 2007 5XTL Biopharmaceuticals Announces Financial Results for the Six Months Ended June 30, 2007 6XTL Biopharmaceuticals Announces Financial Results for the Six Months Ended June 30, 2007 7XTL Biopharmaceuticals Announces Financial Results for the Six Months Ended June 30, 2007 8XTL Biopharmaceuticals Announces Financial Results for the Six Months Ended June 30, 2007 9XTL Biopharmaceuticals Announces Financial Results for the Six Months Ended June 30, 2007 10XTL Biopharmaceuticals Announces Financial Results for the Six Months Ended June 30, 2007 11XTL Biopharmaceuticals Announces Financial Results for the Six Months Ended June 30, 2007 12XTL Biopharmaceuticals Announces Financial Results for the Six Months Ended June 30, 2007 13XTL Biopharmaceuticals Announces Financial Results for the Six Months Ended June 30, 2007 14Warner Chilcott Announces Receipt of Paragraph IV Certification Notice 2Warner Chilcott Announces Receipt of Paragraph IV Certification Notice 3Thoratec Announces HeartMate II(R) PMA Will be Reviewed by FDA Advisory Panel 2
... KLH-conjugated, synthetic peptide corresponding ... of mouse p19ARF. The ... acids 62-75. Clone 5-C3-1. ... by immunoblot. Stability ...
... siSolutions siRNA Custom Synthesis Service ... duplex RNA to knockdown any ... (19 RNA base pairs with ... 27-mers, or other lengths of ...
Request Info...
Tracker Datamatrix RS-1* reads 96 2D Bar-coded tubes within 20 seconds....
Biology Products: